Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
---|
04/08/2014 | US8691949 Peptide having anti-diabetic activity and use thereof |
04/08/2014 | US8691943 Antimicrobial activity of chicken NK-2 peptide against apicomplexan protozoa |
04/08/2014 | US8691941 Method for producing peptide |
04/08/2014 | US8691848 Inhibitors of caspases |
04/08/2014 | US8691770 Method for processing microbiologically produced cyclic oligopeptides |
04/03/2014 | US20140094420 Hydrogel-forming material |
04/03/2014 | US20140094413 Hepatocyte growth factor (hgf) mimics as therapeutic agents |
04/03/2014 | US20140093897 Aromatic-cationic peptides and uses of same |
04/03/2014 | US20140093473 Amphiphilic linear peptidepeptoid and hydrogel comprising the same |
04/02/2014 | CN1665832B Process for producing sugar peptide having asparagine sugar chain and the sugar peptide |
04/02/2014 | CN103703017A A process for extraction of peptides and its application in liquid phase peptide synthesis |
04/02/2014 | CN103694351A Inhibitors of receptor tyrosine kinases and methods of use thereof |
04/02/2014 | CN103694314A Preparation method of active peptide with snake venom source |
04/02/2014 | CN103694313A Glycyl-L-glutamine preparation method |
04/02/2014 | CN102993269B Cyclo-tetrapeptide compounds, preparation method thereof and application of cyclo-tetrapeptide compounds in preparation of anti-fouling agent |
04/02/2014 | CN102827246B Large cyclic heterocyclic compound for inhibiting hepatitis C virus as well as preparation and application thereof |
04/02/2014 | CN102796166B Glucose-modified 4H-beta-carboline carboxylic acid derivative and preparation method and application thereof |
04/02/2014 | CN102690326B Novel gossypol derivate with anti-HIV activity and preparation method thereof |
04/02/2014 | CN102558299B Synthetic polypeptide and application thereof |
04/02/2014 | CN101535336B Synthetic peptide amides and dimers thereof |
04/01/2014 | US8686110 Therapeutic pro-apoptotic BH3-like molecules and methods for generating and/or selecting the same |
04/01/2014 | US8685955 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
04/01/2014 | US8685927 Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolyzate |
04/01/2014 | US8685399 PAX 5 monoclonal antibody |
04/01/2014 | CA2619941C F-18 peptides for pre targeted positron emission tomography imaging |
04/01/2014 | CA2604967C Pyrimidine derivatives and their use as p2y12 receptor antagonists |
03/27/2014 | WO2014047199A1 Novel prodrugs for selective anticancer therapy |
03/27/2014 | WO2014044622A1 2-oxo-2,3,4,5-tetrahydro-1 h-benzo[b]diazepines and their use in the treatment of cancer |
03/27/2014 | US20140088023 sGCalpha1 Inhibiting Compositions, and Methods of Treatment of Cancers Therewith |
03/27/2014 | US20140088004 Hepatocyte Growth Factor Mimics as Therapeutic Agents |
03/27/2014 | US20140087997 Anti-microbial peptides and uses of same |
03/27/2014 | US20140087992 Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof |
03/27/2014 | US20140086936 Matriptase inhibitors and uses thereof against orthomyxoviridae infections |
03/27/2014 | CA2877188A1 2-oxo-2,3,4,5-tetrahydro-1 h-benzo[b]diazepines and their use in the treatment of cancer |
03/26/2014 | CN103687846A Benzylamine derivatives as inhibitors of plasma kallikrein |
03/26/2014 | CN103665103A Method for separating out prostatic cancer (PC)-3 anticancer peptide by utilizing thermal reactant of setipinna taty antibacterial peptide liquid and anticancer peptide obtained by using method |
03/26/2014 | CN103665102A Synthesis method for GHK tripeptide |
03/26/2014 | CN103665101A Pristinamycin IIA crystal |
03/26/2014 | CN102603864B Synthesis and gel property of dendritic gel factor taking phenylalanine and glycine as construction units |
03/26/2014 | CN102504013B Target chemical drug PADM against cancer metastasis and preparation method and use thereof |
03/25/2014 | US8680046 Inhibitors of viral integrase and methods of use |
03/25/2014 | CA2587284C Tripeptide and tetrapeptide thioethers |
03/20/2014 | WO2014040709A1 Pyridomycin based compounds exhibiting an antitubercular activity |
03/20/2014 | US20140080763 N-carboxyalkylauristatins and use thereof |
03/20/2014 | US20140080753 Compounds for enzyme inhibition |
03/20/2014 | US20140080175 Processes for preparing tubulysin derivatives and conjugates thereof |
03/20/2014 | US20140079664 Tripeptides Incorporating Deuterium as Inhibitors of Hepatitis C Virus |
03/19/2014 | EP2707394A2 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof |
03/19/2014 | EP2707023A2 Compositions and methods for immunization against drug resistant acinetobacter baumannii |
03/19/2014 | CN103649292A Stabilized subtilisin composition |
03/19/2014 | CN103649106A Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases |
03/19/2014 | CN103642882A Process for producing dipeptides |
03/19/2014 | CN103642034A Temperature sensitive type dendronized polypeptide polymer and preparation method thereof |
03/19/2014 | CN103641925A Covalent polycompound of water-soluble polysaccharide and taxane compound, and preparation method and medical application of covalent polycompound |
03/19/2014 | CN103641887A Method for separating and purifying glutamine dipeptide by employing D301 macroporous resin |
03/19/2014 | CN103641886A Method for refining glutamine dipeptide |
03/19/2014 | CN101454309B Synthesis and uses of pyroglutamic acid derivatives |
03/18/2014 | US8674072 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolyzate that can reinforce the barrier function |
03/18/2014 | US8674069 MELK epitope peptides and vaccines containing the same |
03/18/2014 | US8674061 Multiligand constructs |
03/18/2014 | US8674020 Process for preparing polyamides |
03/18/2014 | US8673850 PCSK9 inhibitors and methods of use thereof |
03/18/2014 | US8673842 Polypeptoid pulmonary surfactants |
03/18/2014 | US8673590 Method for producing dipeptide |
03/18/2014 | US8673270 RGD-containing peptidomimetics and uses thereof |
03/18/2014 | CA2740815C New uses for amino acid anticonvulsants |
03/18/2014 | CA2636765C Cycloalkylcarbonylamino acid ester derivative and process for producing the same |
03/13/2014 | WO2013190509A3 Preparation of intermediates of boceprevir |
03/13/2014 | WO2013184960A3 Chimeric fibroblast growth factor 23 proteins and methods of use |
03/13/2014 | WO2013181461A3 Metal abstraction peptide with superoxide dismutase activity |
03/13/2014 | WO2013178682A3 Multicomponent process for the preparation of bicyclic compounds |
03/13/2014 | US20140073763 Psma binding ligand-linker conjugates and methods for using |
03/13/2014 | US20140073579 SMAC Mimetic |
03/13/2014 | US20140073573 Trypsin-like serine protease inhibitors, and their preparation and use |
03/12/2014 | EP2705049A1 Hepatitis c virus inhibitors |
03/12/2014 | CN103635485A Solid oxidized glutathione salt and method for producing same |
03/12/2014 | CN103635484A Macrocyclic compounds and methods for their production |
03/12/2014 | CN103626845A Arylpyrrole-2-formamide dipeptide derivatives serving as glycogen phosphorylase inhibitor and preparation method and medical application thereof |
03/12/2014 | CN103626844A Artificial synthetic wheat germ peptide and preparation method and application thereof |
03/12/2014 | CN103626843A Impurity control method for production of aspartame |
03/12/2014 | CN103626842A Water phase condensation method for production of aspartame |
03/12/2014 | CN103626841A Neutralization and crystallization method for aspartame |
03/12/2014 | CN103626840A Preparation method for aspartame from raw materials containing chiral isomer |
03/12/2014 | CN103626839A Preparation method of N(2)-L-alanyl-L-glutamine |
03/12/2014 | CN103626838A Removal method of endotoxin in N-(2)-L-alanyl-L-glutamine active pharmaceutical ingredient |
03/12/2014 | CN103626837A Glycogen phosphorylase inhibitor cholic acid derivative containing bio-cleavable dipeptide and preparation method and medical application thereof |
03/12/2014 | CN103623777A Active adsorbent and application thereof in N(2)-L-alanyl-L-glutamine production process |
03/12/2014 | CN103012552B Bioactive polypeptide QEPV, and preparation and application thereof |
03/12/2014 | CN102229650B High purity lipopeptides, lipopeptide micelles and processes for preparing same |
03/12/2014 | CN101605806B Crystalline D-isoglutamyl-D-tryptophan and mono ammonium salt of D-isoglutamyl- D-tryptophan |
03/12/2014 | CN101261277B Promyostatin peptides and methods of using same |
03/11/2014 | US8669345 Nogo receptor antagonists |
03/06/2014 | WO2014033667A1 Process for the preparation of telaprevir |
03/06/2014 | US20140066380 Peptide fragments for inducing synthesis of extracellular matrix proteins |
03/06/2014 | US20140066361 Peptides and use thereof in the inhibition of angiotensin converting enzyme |
03/06/2014 | US20140065176 T-cell death-inducing epitopes |
03/05/2014 | EP2703008A1 Human antibodies to PCSK9 for use in methods of treating particular groups of subjects |
03/05/2014 | CN103619869A Macrocyclic compound and methods for its production |
03/05/2014 | CN103613641A Method for separating and purifying polyoxins |
03/05/2014 | CN103613640A Bortezomib crystal form J and preparation method thereof |